Free press releases distribution network?

Agency / Source: Eagle Summit Corp

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Life Sciences Venture Capital Investment Level Rebounds in Q1 201 Notes Eagle Summit Corporation - The first quarter investment total sets us on a path for a solid level of investing in 2011 - EagleSummitCorp.com
Life Sciences Venture Capital Investment Level Rebounds in Q1 201 Notes Eagle Summit Corporation

 

PRZOOM - /newswire/ - Nicosia, Cyprus, 2011/05/17 - The first quarter investment total sets us on a path for a solid level of investing in 2011 - EagleSummitCorp.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Venture capital funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, recovered in terms of dollar investments during the first quarter of 2011.

Venture investment for the Life Sciences sector grew by 7 percent in dollars year over year to $1.4 billion. Deal volume, however, declined 8 percent compared to the first quarter of 2010, dropping to 164 deals in Q1 2011. The quarterly deal count represents the lowest number in a single quarter since the first quarter of 2009.

The first quarter investment total sets us on a path for a solid level of investing in 2011. Venture funds are expected to continue being cautious about investing in life sciences as the economic recovery progresses, but their stated interest in the sector is long term. They recognize the potential of an industry that is only beginning to embark on a new era of personalized medicine to deliver more effective and targeted treatments that could improve the health of millions of people in all regions of the world.

During the first quarter of 2011, the share of Biotechnology investments decreased to 57 percent, while the Medical Device industry's share increased to 43 percent. Compared with the first quarter of 2010, the investment split remained unchanged.

For all sectors, venture capitalists invested $5.9 billion in 736 deals in Q1 2011, a 14 percent increase in dollars and a 6 percent decrease in deals, compared to $5.2 billion going into 787 deals in Q1 2010. The Life Sciences share of total venture capital dollars invested slipped slightly to 24 percent in the first quarter of 2011 from 25 percent in the first quarter of 2010.

In Q1 2011, Biotechnology investing grew by 5 percent in dollars but dropped 21 percent in deals year over year with $784 million going into 85 deals. Medical device investments increased 9 percent in dollars and 11 percent in deals in Q1 2011, compared to the same quarter a year ago. With $602 million going into 79 deals, the Medical Device industry ranked behind Software, Industrial/Energy, and Biotechnology in dollars invested.

During the first quarter of 2011, 35 Life Sciences companies received venture capital funding for the first time, capturing $129 million. This represents a sharp decline of 40 percent in the number of companies and a 46 percent drop in dollars invested compared to the first quarter of 2010. First-time deals in the Life Sciences sector averaged $3.7 million in the first quarter of 2011, compared with an average deal size of $6.1 million in the first quarter of 2010.

First-time funding is expected to remain challenging for the sector, with fewer deals and smaller deal size for fledgling companies. Lengthy and costly R&D and uncertainty in the regulatory approval process continue to drive more investors toward follow-on and later-stage deals with companies that are closer to successful product launches or the exit market.

Four of the seven Biotechnology subsegments exhibited growth in the first quarter of 2011 compared to the first quarter of 2010. Dollars invested in the Biotech Research, Biotech Industrial, Biotech Equipment, and Biotech Human subsegments rose 158 percent, 89 percent, 7 percent and 4 percent, respectively. The Human Biotechnology subsegment captured the largest share in the first quarter with $493 million going into 54 deals, a 4 percent increase in dollars and a 16 percent decrease in deals from Q1 of 2010.

Funding for two of the three Medical Device subsegments increased in Q1 2011, compared with the same quarter of 2010. The Medical Therapeutics category accounted for nearly two-thirds of the dollars and 62 percent of the deals during the first quarter with $391 million going into 49 deals. This represents a 26 percent increase in deals and a 30 percent increase in dollars compared to the first quarter of 2010.

About Eagle Summit Corporation

Founded in 2005 and based in Cyprus, the goal at Eagle Summit Corp (eaglesummitcorp.com) is a simple one: to work with talented entrepreneurs and management teams to develop ground-breaking products and build substantial business enterprises around them. We have raised a series of partnerships, with current committed capital in excess of $450 million, and helped build hundreds of companies, 60 of which have gone on to successful IPOs and more than 45 of which have gone on to successful mergers.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Eagle Summit Corp

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Financial/Legal/Venture articles,
CATCH Visitors via Your Competitors Announcements!


Life Sciences Venture Capital Investment Level Rebounds in Q1 201 Notes Eagle Summit Corporation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Hector Kosko - EagleSummitCorp.com 
+357-22007774 press[.]eaglesummitcorp.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Eagle Summit Corp securities in any jurisdiction including any other companies listed or named in this release.

Financial/Legal/Venture via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Eagle Summit Corp / Company Profile


Read Financial/Legal/Venture Most Recent Related Press Releases:

Infinera to Participate in Upcoming Investor Conference
Propel Financial Services Partners with Clear Payment Solutions
Digital Payments Power Growth in Booming Asia-Pacific Financial Technology Landscape Notes Frost & Sullivan
Digital Readiness Key to Growth Opportunities in the Financial Services Market
Prairie Capital Advisors Announces The Sale of Cornerstone Treatment Facilities Network to An ESOP
Koch Agrees to Invest Over $2 Billion in Infor
FTI Consulting Recognized as a Top Service Provider in the Legal Industry
GE Completes Spin Off and Demerger of Bank BPH Core Bank to Alior Bank
ALM Expands Senior Leadership Team, Organization Focused on Customers and Transformation
Lazard Acquires Remaining 50% Stake in MBA Lazard - Fully Integrating its Latin American Operations

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today